Yat Sun Or

(Dr. Yat Sun Or Ph.D.)

Currently holds a position at Enanta Pharmaceuticals Inc

Positions

Position Company Period
Senior Vice President - Research & Development, Chief Scientific Officer Enanta Pharmaceuticals Inc Nov. 1, 1999 -
Yat Sun Or's trades of Enanta Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-10 2024-12-06
S Sale
2,591 -0.7%
8.06
USD 20,883 		2,591 -0.7% 8.06 USD 20,883
2023-12-06 2023-12-05
S Sale
2,412 -0.6%
9.63
USD 23,228 		2,412 -0.6% 9.63 USD 23,228
2023-03-17 2023-03-15
PS Planned sale
13,656 -3.5%
44.46
USD 607,146 		13,656 -3.5% 44.46 USD 607,146
2023-03-17 2023-03-15
PS Planned sale
269 -0.1%
43.92
USD 11,814 		269 -0.1% 43.92 USD 11,814
2019-03-04 2019-03-01
PS Planned sale
4,090 -1.3%
103.84
USD 424,693 		4,090 -1.3% 103.84 USD 424,693
2019-03-04 2019-03-01
PS Planned sale
5,910 -1.9%
103.32
USD 610,628 		5,910 -1.9% 103.32 USD 610,628
2019-02-13 2019-02-12
PS Planned sale
6,297 -2.0%
90.07
USD 567,173 		6,297 -2.0% 90.07 USD 567,173
2019-02-13 2019-02-11
PS Planned sale
171 -0.1%
91.24
USD 15,602 		171 -0.1% 91.24 USD 15,602
2019-02-13 2019-02-11
PS Planned sale
2,707 -0.9%
90.11
USD 243,936 		2,707 -0.9% 90.11 USD 243,936
2019-02-13 2019-02-11
PS Planned sale
18,971 -5.7%
89.50
USD 1,697,878 		18,971 -5.7% 89.50 USD 1,697,878
2019-02-13 2019-02-11
PS Planned sale
5,835 -1.7%
88.66
USD 517,321 		5,835 -1.7% 88.66 USD 517,321
// ... existing code ... // ... rest of the file ...